Agency picks risk advisory panelist

Share this article:
The FDA's newly staffed Risk Communication Advisory Committee will begin reviewing risk communication issues in the first quarter of 2008. After sifting through 240 nominated individuals, the agency in November narrowed its selection down to 15 voting members with diverse backgrounds.

To chair the advisory committee, FDA selected Carnegie Mellon Howard Heinz university professor Baruch Fischhoff, whose expertise is in risk perception and communication. He will serve a four-year term on the committee. Panel members include television journalist and medical contributor on Good Morning America and ABCNews.com Prerna Mona Khanna; PR expert AnnaMaria DeSalva (Hill and Knowlton); and consumer advocate William K. Vaughn (Consumers Union).

The committee will advise the FDA about how best to communicate to the public about the risks and benefits of FDA-regulated products so as to facilitate their optimal use.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?